Metabolic syndrome, high-sensitivity C-reactive protein and the risk of heart failure: the Kailuan cohort study
Authors
- Dandan Zhao (ORCID: https://orcid.org/0000-0001-5194-750X)
- Shuohua Chen (ORCID: https://orcid.org/0000-0002-6274-7471)
- Shouling Wu (ORCID: https://orcid.org/0000-0001-7095-6022)
- Yanxiu Wang (ORCID: https://orcid.org/0000-0002-1220-8672)
- Yun Li (ORCID: https://orcid.org/0000-0001-8414-2724)
- Huayu Sun
- Ying Wu (ORCID: https://orcid.org/0000-0002-6751-9953)
- Yan Tian (ORCID: https://orcid.org/0000-0002-1194-4440)
- Peng Yang (ORCID: https://orcid.org/0000-0003-3098-7777)
- Hao Wu (ORCID: https://orcid.org/0009-0000-1030-9819)
Institutions
- North China University of Science and Technology (CN)
- Tangshan College (CN)
- Kailuan General Hospital (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-04-22
- DOI
- https://doi.org/10.3389/fendo.2025.1544823
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Science and Technology Major Project